ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $784,953 | -24.4% | 29,213 | +0.4% | 0.00% | 0.0% |
| Q2 2023 | $1,037,813 | +22.5% | 29,103 | -12.7% | 0.00% | 0.0% |
| Q1 2023 | $847,166 | -37.4% | 33,353 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $1,352,798 | +14.9% | 33,353 | -6.3% | 0.00% | 0.0% |
| Q3 2022 | $1,177,000 | -6.1% | 35,613 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,254,000 | -23.4% | 35,613 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $1,638,000 | -35.6% | 35,613 | -7.1% | 0.00% | -40.0% |
| Q4 2021 | $2,542,000 | +4.9% | 38,343 | -1.2% | 0.01% | 0.0% |
| Q3 2021 | $2,424,000 | -24.6% | 38,821 | 0.0% | 0.01% | -16.7% |
| Q2 2021 | $3,215,000 | +26.8% | 38,821 | +1.6% | 0.01% | +20.0% |
| Q1 2021 | $2,535,000 | -22.8% | 38,222 | -10.7% | 0.01% | -28.6% |
| Q4 2020 | $3,284,000 | +76.5% | 42,802 | -1.0% | 0.01% | +75.0% |
| Q3 2020 | $1,861,000 | +1.7% | 43,222 | +2.0% | 0.00% | -20.0% |
| Q2 2020 | $1,830,000 | +50.1% | 42,372 | 0.0% | 0.01% | +25.0% |
| Q1 2020 | $1,219,000 | -64.6% | 42,372 | -22.0% | 0.00% | -50.0% |
| Q4 2019 | $3,444,000 | +150.1% | 54,298 | +11.1% | 0.01% | +100.0% |
| Q3 2019 | $1,377,000 | +23.6% | 48,868 | +16.3% | 0.00% | +33.3% |
| Q2 2019 | $1,114,000 | +57.6% | 42,032 | +9.0% | 0.00% | +50.0% |
| Q1 2019 | $707,000 | +47.6% | 38,552 | 0.0% | 0.00% | +100.0% |
| Q4 2018 | $479,000 | -28.6% | 38,552 | +10.1% | 0.00% | -50.0% |
| Q3 2018 | $671,000 | +49.4% | 35,010 | +6.0% | 0.00% | +100.0% |
| Q2 2018 | $449,000 | +944.2% | 33,040 | +43.6% | 0.00% | – |
| Q1 2017 | $43,000 | +19.4% | 23,004 | 0.0% | 0.00% | – |
| Q4 2016 | $36,000 | -78.7% | 23,004 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $169,000 | +38.5% | 23,004 | 0.0% | 0.00% | – |
| Q2 2016 | $122,000 | – | 23,004 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,264 | $54,392,000 | 33.22% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $216,228,000 | 28.00% |
| L1 Capital Pty Ltd | 296,024 | $19,629,000 | 4.93% |
| Aquilo Capital Management, LLC | 407,926 | $27,050,000 | 4.89% |
| Evolutionary Tree Capital Management, LLC | 72,948 | $4,837,000 | 2.86% |
| ACUTA CAPITAL PARTNERS, LLC | 108,000 | $7,161,000 | 2.58% |
| First Light Asset Management, LLC | 536,836 | $35,598,000 | 2.36% |
| Parkman Healthcare Partners LLC | 70,089 | $4,648,000 | 1.08% |
| Hood River Capital Management LLC | 357,082 | $23,678,000 | 0.76% |
| Vanguard Capital Wealth Advisors | 11,099 | $703,565,000 | 0.60% |